Last Updated : January 17, 2024
Event date: January 17, 2024
Time: 2:00 p.m. to 2:45 p.m. ET
Zoom webinar (free — registration required)
In September 2022, CADTH launched the Post-Market Drug Evaluation (PMDE) program. CADTH’s PMDE program focuses solely on providing answers to decision-makers' questions about the safety and effectiveness of drugs, whether they are existing or new products.
The program has been designed to maximize CADTH’s access to a wide range of applied researchers, data analysts, and methodologists from across Canada. Our goal is to ensure stability while balancing the need to be continually responsive to the needs of decision-makers. To meet future needs, the PMDE program has launched a Request for Standing Offers (RFSO) process to recruit more individuals and teams to join CoLab, our network of researchers.
For an overview of the RFSO process, plan to attend our 45-minute information session. You will have the opportunity to:
- learn about the PMDE Program and its pan-Canadian query response network
- understand how to respond to the RFSO for contract funding
- ask questions through a live question and answer forum.
There is no cost to attend, but registration is required. After registering, you will receive a confirmation email with information about how to join the webinar.
Presenters:
- Tarry Ahuja, Director, PMDE Program
- Nadine Sulatycky, PMDE Program Lead
The questions and answers from the information session will be posted on CADTH’s website by January 24, 2024.
Last Updated : January 17, 2024